Bipolar Disorder Clinical Trials in Fort Worth

View 18 new treatments for Bipolar Disorder in Fort Worth, TX near me. Every day, Power helps hundreds of Bipolar Disorder patients connect with leading medical research.
View 18 trials in Fort Worth
Filter (18)

Multiple Medications for Bipolar Depression

Research Clinic, Dallas + 1 more

This trial is testing four different medications to find the best treatment for adults with bipolar disorder type 1 who are currently depressed. The medications work by balancing brain chemicals that affect mood. The goal is to help patients recover from depression and stay well.Show More
Waitlist

No Placebo Trial

Phase 4
Est. 6 - 12 Weeks
Unregistered Study Lead
Research Team

Iloperidone Safety for Adolescent Schizophrenia

Vanda Clinic, DeSoto + 1 more

To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment.
Recruiting

No Placebo Trial

Phase 4
Est. 6 - 12 Weeks
Unregistered Study Lead
Research Team

Clozapine vs Risperidone for Psychosis

Research Clinic, Dallas + 1 more

The CLOZAPINE study is designed as a multisite study across 5 sites and is a clinical trial, involving human participants who are prospectively assigned to an intervention. The study will utilize a stringent randomized, double-blinded, parallel group clinical trial design. B2 group will serve as psychosis control with risperidone as medication control. The study is designed to evaluate effect of clozapine on the B1 participants, and the effect that will be evaluated is a biomedical outcome. The study sample will be comprised of individuals with psychosis, including 1) schizophrenia, 2) schizoaffective disorder and 3) psychotic bipolar I disorder. The investigators plan to initially screen and recruit n=524 (from both the existing B-SNIP library and newly-identified psychosis cases, \~50% each) in order to enroll n=320 (B1 and B2) into the RCT.Show More
Recruiting
Phase 4
Est. 6 - 12 Weeks
Carol Tamminga, M.D.
Principal Investigator

Cariprazine for Bipolar Disorder in Youth

AbbVie Clinic, Mansfield + 3 more

This trial is testing the safety and effectiveness of Cariprazine for treating depressive episodes in children and teenagers with bipolar I disorder. The goal is to find out if Cariprazine can help young people with this condition. Cariprazine is an atypical antipsychotic recently approved for the treatment of depressive episodes in adults with bipolar I disorder.Show More
Recruiting
Phase 3
Est. 6 - 12 Weeks
ABBVIE INC.
Study Director

NRX-101 for Bipolar Depression

NeuroRx Clinic, Fort Worth + 1 more

This trial tests a two-step treatment for adults with severe bipolar depression and suicidal thoughts. It starts with a quick-acting ketamine dose followed by an oral medication to maintain improvement. The goal is to see if this approach is better than using lurasidone alone. Ketamine has been shown to rapidly reduce depressive and suicidal symptoms in both unipolar and bipolar depression.Show More
Waitlist

No Placebo Trial

Phase 3
Est. 6 - 12 Weeks
Martin Brecher, MD
Study Director

Lumateperone for Pediatric Bipolar Depression

Intra-Cellular Therapies Clinic, Frisco + 1 more

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients who are experiencing major depressive episodes (MDEs) associated with a primary diagnosis of bipolar I or bipolar II disorder as confirmed by Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL), according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5).Show More
Recruiting
Phase 3
Est. 6 - 12 Weeks
Unregistered Study Lead
Research Team

Lumateperone for Bipolar Mania

Intra-Cellular Therapies Clinic, Richardson + 1 more

This is a multicenter, randomized, double-blind, placebo-controlled, study in the acute treatment of patients with a diagnosis of bipolar I disorder with manic episodes or manic episodes with mixed features (bipolar mania), with or without psychotic symptoms, according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5).Show More
Recruiting
Phase 3
Est. 3 - 6 Weeks
Unregistered Study Lead
Research Team

Dexmedetomidine for Agitation in Schizophrenia and Bipolar Disorder

BioXcel Clinic, Plano + 4 more

In this study, an investigational medication named BXCL501 is being tested for the treatment of episodes of agitation associated with bipolar I and bipolar II disorder, schizophrenia, schizoaffective and schizophreniform disorder. This study compares the study drug to a placebo.Show More
Recruiting
Phase 3
Est. 5 - 8 Weeks
Robert Risinger, MD
Study Chair

Cariprazine for Pediatric Schizophrenia

AbbVie Clinic, Plano + 3 more

This trial is testing the safety and effectiveness of cariprazine in children and teens with schizophrenia, bipolar I disorder, or autism. The goal is to see if the medication is safe and beneficial for use in these young patients.Show More
Waitlist

No Placebo Trial

Phase 3
Est. 6 - 12 Weeks
ALLERGAN INC.
Study Director

OLZ/SAM for Schizophrenia

Alkermes Clinic, Fort Worth + 3 more

This trial evaluates the safety and tolerability of OLZ/SAM in children and adolescents with schizophrenia or Bipolar I disorder. OLZ/SAM combines olanzapine to manage symptoms and samidorphan to reduce weight gain. Olanzapine is a well-established antipsychotic effective for schizophrenia and bipolar I disorder, but its use is limited by significant weight gain; samidorphan is added to mitigate this side effect.Show More
Waitlist

No Placebo Trial

Phase 3
Est. 3 - 6 Weeks
David McDonnell, MD
Study Director
Page 1 of 2

Frequently Asked Questions

How much do bipolar clinical trials pay?

Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range. Further, most trials will cover the costs of an Uber to-and-from the clinic. Factors that can affect compensation include the phase of the trial, the length of the trial, the frequency of visits, and the specific condition being studied.

Do I need to be insured to participate in a medical study?

Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on Cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.

How do bipolar clinical trials work?

After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll typical be sorted into one of the treatment groups, and will receive your study drug. For some trials, there is a chance you'll receive a placebo. Across bipolar trials in Fort Worth, 42% of clinical trials have a placebo. Typically you'll be required to check-in with the clinic every month or two. The average trial length in this city for bipolar patients is 6 Months.

What does the "phase" of a clinical trial mean?

The phase of a trial reveals what stage the drug is in getting approval for a specific condition. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. Phase 2 trials are those where the drug has some data showing safety in humans, but where effectiveness has typically only been shown in animals and non-human experiments. Phase 1 trials are the trials where we don't have safety data in humans. As a general rule, phase 3 trials are more promising than phase 2, and phase 2 trials are more promising than phase 1.

Where in Fort Worth is research being conducted for bipolar?

JP Smith Hospital in Fort Worth is conducting clinical trials for bipolar disorder, with approximately 2 trials ongoing. These trials are taking place in the southern part of the city.

What promising new drugs are being tested?

In Fort Worth, research for bipolar disorder includes treatments like Atypical Antipsychotics and NMDA Antagonists. Specific drugs being studied are Lurasidone HCl, Olanzapine, and NRX-101.